CSPC Innovation Pharmaceutical Co Ltd Class A (300765) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.009x

Based on the latest financial reports, CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a cash flow conversion efficiency ratio of -0.009x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.98 Million ≈ $-3.80 Million USD) by net assets (CN¥2.80 Billion ≈ $409.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of CSPC Innovation Pharmaceutical Co Ltd Cl for the company's overall valuation and market capitalisation.

CSPC Innovation Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CSPC Innovation Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CSPC Innovation Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Explore 300765 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	0.025x
KT Corporation NYSE:KT	0.034x
Sangfor Technologies Inc Class A SHE:300454	0.029x
Pentair PLC NYSE:PNR	-0.018x
Sirius XM Holding Inc NASDAQ:SIRI	0.023x
Crinetics Pharmaceuticals Inc NASDAQ:CRNX	-0.079x
Nova Ltd TA:NVMI	0.050x
Baloise Holding AG SW:BALN	0.211x

Annual Cash Flow Conversion Efficiency for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. View CSPC Innovation Pharmaceutical Co Ltd Cl (300765) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.80 Billion ≈ $409.04 Million	CN¥-195.69 Million ≈ $-28.64 Million	-0.070x	+74.52%
2024-12-31	CN¥4.50 Billion ≈ $657.90 Million	CN¥-1.24 Billion ≈ $-180.73 Million	-0.275x	-262.45%
2023-12-31	CN¥5.48 Billion ≈ $802.37 Million	CN¥927.24 Million ≈ $135.68 Million	0.169x	+4.10%
2022-12-31	CN¥3.94 Billion ≈ $577.16 Million	CN¥640.72 Million ≈ $93.76 Million	0.162x	+83.40%
2021-12-31	CN¥3.30 Billion ≈ $482.55 Million	CN¥292.09 Million ≈ $42.74 Million	0.089x	-31.82%
2020-12-31	CN¥2.69 Billion ≈ $393.18 Million	CN¥349.07 Million ≈ $51.08 Million	0.130x	-0.51%
2019-12-31	CN¥2.42 Billion ≈ $353.44 Million	CN¥315.38 Million ≈ $46.15 Million	0.131x	-18.30%
2018-12-31	CN¥999.35 Million ≈ $146.24 Million	CN¥159.73 Million ≈ $23.37 Million	0.160x	+9327.66%
2017-12-31	CN¥766.93 Million ≈ $112.23 Million	CN¥1.30 Million ≈ $190.26K	0.002x	-99.29%
2016-12-31	CN¥572.02 Million ≈ $83.70 Million	CN¥137.27 Million ≈ $20.09 Million	0.240x	+34.25%
2015-12-31	CN¥626.83 Million ≈ $91.72 Million	CN¥112.05 Million ≈ $16.40 Million	0.179x	+2.85%
2014-12-31	CN¥537.16 Million ≈ $78.60 Million	CN¥93.36 Million ≈ $13.66 Million	0.174x	--

About CSPC Innovation Pharmaceutical Co Ltd Class A

SHE:300765 China Packaged Foods

Market Cap

$9.02 Billion

CN¥61.63 Billion CNY

Market Cap Rank

#2427 Global

#280 in China

Share Price

CN¥43.88

Change (1 day)

+1.41%

52-Week Range

CN¥23.23 - CN¥51.78

All Time High

CN¥189977.21